Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Intercambio y inovación: la cosmología psiquiátrica
1
x
$
0.00
Karen Dineen Wagner, MD, PhD: Management of Bipolar Disorder in Children and Adolescents
1
x
$
30.00
K. Ranga Rama Krishnan, MB, ChB: Evidence-Based Mental Health
1
x
$
30.00
La guía 2016 sobre interacciones entre medicamentos psicotrópicos, Part 2
1
x
$
15.00
Efficacy of Duloxetine for the Treatment of Depression: Relationship to Most Recent Antidepressant Trial
1
x
$
30.00
View Cart
Checkout
Home
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
$
30.00
Gahan J. Pandina: Adjunctive Risperidone in the Treatment of Generalized Anxiety Disorder: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
SKU:
pb-40-3-pandina
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
carla-m-canuso
,
gahan-j-pandina
,
generalized-anxiety-disorder
,
ibrahim-turkoz
,
mary-kujawa
,
md
,
mph
,
ms
,
phd
,
ramy-a-mahmoud
,
risperidone-adjunctive-treatment
,
selective-serotonin-receptor-inhibitors
Description
Description
Gahan J. Pandina, PhD
Link
NEGATIVE AND FAILED CLINICAL TRIAL REPORTS
Adjunctive Risperidone in the Treatment of
Generalized Anxiety Disorder
: A Double-Blind, Prospective, Placebo-Controlled, Randomized Trial
Gahan J. Pandina, PhD, Carla M. Canuso, MD, Ibrahim Turkoz, MS, Mary Kujawa, MD, PhD, and Ramy A. Mahmoud, MD, MPH
Related products
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
$
30.00
Add to cart
Details
Srinivas G. Rao, MD, PhD: Understanding The Fibromyalgia Syndrome
$
30.00
Add to cart
Details
Page load link
Go to Top